#CardiovascularCare #PharmaInnovation #Repatha #HeartHealth #ClinicalResearch To view or add a comment, sign in A new study presented at the European Society of Cardiology Congress 2025, powered by Truveta Data from more than 200,000 patients, found: Early discontinuation was linked to higher cardiovascular risks
If someone needs semaglutide or tirzepatide to keep [their] glucose normal, the medication is functioning as chronic treatment
By enhancing satiety and reducing appetite in this fashion, the drugs promote substantial and sustained weight loss
Since aging is often accompanied by increased oxidative tissue damage and loss of mitochondrial activity, many studies involving CR have focused on the bioenergetic and redox effects of this diet [4, 30], mostly showing that it decreased oxidative damage [5]
So, Does B12 Give You Energy